method u043fu0440u043eu0433u043du043eu0437u0438u0440u043eu0432u0430u043du0438u00a0 threat u043fu0440u0435u0440u044bu0432u0430u043du0438u00a0 pregnancy early time u0433u0435u0441u0442u0430u0446u0438u0438, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 concentration of some specific hormones placenta (u044du0441u0442u0440u0438u043eu043bu0430, u043fu043bu0430u0446u0435u043du0442u0430u0440u043du043eu0433u043e u043bu0430u043au0442u043eu0433u0435u043du0430), levels of interleukin 6 and u0432u044bu0447u0438u0441u043bu00a0u044eu0442 diagnostic indicator (d) by the formula:;d = X1K1 + u04452u043a2 + u04453u043a3 + const...;where x1 is u043au043eu043du0446u0435u043du0442u0440u0430u0446u0438u00a0 u044du0441u0442u0440u0438u043eu043bu0430, ng / ml;;h2 is the level of interleukin 6, pg / ml;;the x3 is the number of u043fu043bu0430u0446u0435u043du0442u0430u0440u043du043eu0433u043e u043bu0430u043au0442u043eu0433u0435u043du0430, mg / l;;k1 = 0.05;;k2 = 0.07.;k3 = 0.18;;const = 0.37.;and d less than 0 makes a conclusion that there is no laboratory evidence of u0440u0430u0437u0432u0438u0442u0438u00a0 threat u043fu0440u0435u0440u044bu0432u0430u043du0438u00a0 pregnancy, and d a, u0434u0438u0430u0433u043du043eu0441u0442u0438u0440u0443u044eu0442 availability of laboratory characteristics of u0434u043bu00a0 u0440u0430u0437u0432u0438u0442u0438u00a0 this pathology.
展开▼